Description
The Firm intends to develop and validate a novel recombinant antibody discovery platform using a chicken immune system. This platform will allow scientists to reach into unexplored regions of protein targets (i.e. novel epitopes) by exploi…
Amendment chain · 2 entries
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $0 at start, $304,637 after amendment #3 (+$304,637).
- #22018-06-25$0
- #32019-01-02$304,637+$304,637
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2018-06-25 | $0 | — | The Firm intends to develop and validate a novel recombinant antibody discovery platform using a chicken immun… |
| #3 amendment | 2019-01-02 | $304,637 | +$304,637 | The Firm intends to develop and validate a novel recombinant antibody discovery platform using a chicken immun… |
Related records · 11
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 806733887)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 276-2025-2026-Q4-00103 | Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique · REGI-BSP-Regional Tariff Response Initiative (RTRI) | $747,500 | FY2026 |
| 276-2025-2026-Q4-00084 | Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique · REGI - Strategic Growth Initiative (SGI) | $50,000 | FY2026 |
| 064-2025-2026-Q2-00089 | Global Affairs Canada | Affaires mondiales Canada · Grant Canadian Inter. Innovation Prog | $2,927 | FY2026 |
| 172-2025-2026-Q2-1031776 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $1,000,000 | FY2026 |
| 276-2022-2023-Q3-00103 | Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique · REGI - Business Scale-up and Productivity | $700,000 | FY2023 |
| 276-2022-2023-Q2-00417 | Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique · REGI - Business Scale-up and Productivity | $1,250,000 | FY2023 |
Other recipients funded under "Industrial Research Assistance Program – Contributions to Firms" by National Research Council Canada | Conseil national de recherches Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 172-2025-2026-Q2-1034675 | Mediphage Bioceuticals, Inc. | FY2027 | $63,380 | FY2027 |
| 172-2025-2026-Q3-1037522 | OBKIO INC. | FY2026 | $50,000 | FY2026 |
| 172-2025-2026-Q3-1037889 | SERVICES DE DEVELOPPEMENT PROFESSIONELS SDP INC | FY2026 | $25,000 | FY2026 |
| 172-2025-2026-Q2-1034040 | Griffith Foods Limited | FY2026 | $54,880 | FY2026 |
| 172-2025-2026-Q3-1037273 | Apollo Machine & Welding Ltd. | FY2026 | $230,000 | FY2026 |
Cite as: Glassbox record view · Federal grants & contributions · 172-2018-2019-Q1-885833 · retrieved 2026-11-16.